4.6 Article

Intermediate Charcot-Marie-Tooth disease due to a novel Trp101Stop myelin protein zero mutation associated with debilitating neuropathic pain

期刊

PAIN
卷 153, 期 8, 页码 1763-1768

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.pain.2012.05.015

关键词

Peripheral neuropathy; MPZ; Charcot-Marie-Tooth disease; Neuropathic pain; Quantitative sensory testing; Intraepidermal nerve fibre density

资金

  1. Wellcome Trust

向作者/读者索取更多资源

We report an English kindred affected across 4 generations with a hereditary neuropathy associated with debilitating neuropathic pain as the main clinical feature. The principal finding on clinical examination was sensory loss, and there was variable motor dysfunction. Electrophysiological studies revealed mild features of demyelination with median conduction velocity in the intermediate range. There was an auto-somal-dominant pattern of inheritance, and genetic testing revealed a novel heterozygous Trp101X mutation in exon 3 coding for a portion of the extracellular domain of myelin protein zero. This is predicted to lead to premature termination of translation. Myelin protein zero is a key structural component of compact myelin, and over 100 mutations in this protein have been reported, which can give rise to neuropathies with either axonal, demyelinating, or intermediate features encompassing a wide range of severity. Chronic pain is an increasingly recognised sequela of certain hereditary neuropathies and may be musculoskeletal or neuropathic in origin. In this kindred, the neuropathy was relatively mild in severity, however, neuropathic pain was an important and disabling outcome. (C) 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Anesthesiology

Hepatocyte growth factor, colony-stimulating factor 1, CD40, and 11 other inflammation-related proteins are associated with pain in diabetic neuropathy: exploration and replication serum data from the Pain in Neuropathy Study

Emmanuel Backryd, Andreas Themistocleous, Anders Larsson, Torsten Gordh, Andrew S. C. Rice, Solomon Tesfaye, David L. Bennett, Bjorn Gerdle

Summary: This study aims to explore the pathophysiological mechanisms underlying neuropathic pain in patients with diabetic DSP. It suggests that low-grade systemic inflammation is related to the severity of neuropathy and neuropathic pain, and identifies specific inflammation-related proteins such as hepatocyte growth factor, colony-stimulating factor 1, and CD40 that may play a crucial role in neuropathic pain.
Article Anesthesiology

Systemic inflammatory markers in neuropathic pain, nerve injury, and recovery

Oliver Sandy-Hindmarch, David L. Bennett, Akira Wiberg, Dominic Furniss, Georgios Baskozos, Annina B. Schmid

Summary: The role of inflammation in human nerve injury and neuropathic pain is still not fully understood. This study investigated the changes in cytokine protein levels and gene expression levels before and after carpal tunnel decompression surgery in patients with carpal tunnel syndrome. The results showed specific dysregulation of systemic cytokine expression in both the active and resolution phases of nerve injury and neuropathic pain, suggesting the involvement of inflammation in the resolution of neuropathic pain.
Article Clinical Neurology

Axonal Excitability Does Not Differ between Painful and Painless Diabetic or Chemotherapy-Induced Distal Symmetrical Polyneuropathy in a Multicenter Observational Study

Andreas C. Themistocleous, Alexander G. Kristensen, Roma Sola, Sandra S. Gylfadottir, Kristine Bennedsgaard, Mustapha Itani, Thomas Kroigard, Lise Ventzel, Soren H. Sindrup, Troels S. Jensen, Hugh Bostock, Jordi Serra, Nanna B. Finnerup, Hatice Tankisi, David L. H. Bennett

Summary: A multicenter observational study found no significant difference in axonal excitability between patients with painful and painless diabetic or chemotherapy-induced polyneuropathy.

ANNALS OF NEUROLOGY (2022)

Article Surgery

Replication of epidemiological associations of carpal tunnel syndrome in a UK population-based cohort of over 400,000 people

A. Wiberg, R. W. Smillie, S. Dupre, A. B. Schmid, D. L. Bennett, D. Furniss

Summary: This study utilized the UK Biobank resource to investigate factors associated with carpal tunnel syndrome (CTS), and found that female sex, high BMI, and certain systemic diseases are associated with CTS.

JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2022)

Editorial Material Neurosciences

Harnessing bacterial toxins to treat pain

Jimena Perez-Sanchez, David L. Bennett

Summary: The study showed that sensory neurons are enriched for anthrax toxin receptor-2. Edema toxin acts through this receptor to induce analgesia in mice, and can also be modified to deliver large cargoes like botulinum toxin to selectively silence sensory neurons.

NATURE NEUROSCIENCE (2022)

Article Anesthesiology

Characterisation of the pathophysiology of neuropathy and sensory dysfunction in a mouse model of recessive dystrophic epidermolysis bullosa

Daniela Schmidt, Paula Diaz, Daniela Munoz, Fernanda Espinoza, Alexander Nystrom, Ignacia Fuentes, Marcelo Ezquer, David L. Bennett, Margarita Calvo

Summary: In this study, a mouse model of RDEB was used to investigate the characteristics of the somatosensory system. The results showed that in RDEB, there is distal axonal degeneration caused by damage to small fibres in the epidermis, but without sustained neuroinflammation. This highlights the importance of a healthy cutaneous environment for maintaining epidermal innervation in RDEB patients.
Article Multidisciplinary Sciences

The characteristics of pain and dysesthesia in patients with diabetic polyneuropathy

Sandra Sif Gylfadottir, Mustapha Itani, Alexander Gramm Kristensen, Pall Karlsson, Thomas Kroigard, David L. Bennett, Hatice Tankisi, Niels Trolle Andersen, Troels Staehelin Jensen, Soren Hein Sindrup, Nanna Brix Finnerup

Summary: This study characterized the predictors, symptoms, neuropathy severity, and impact of painful and dysesthetic diabetic polyneuropathy (DPN). The results showed a gradient of increasing sensory loss from DPN without pain or dysesthesia to dysesthetic DPN and to painful DPN, indicating a more severe neuropathy in dysesthetic patients compared to those without dysesthesia but less severe than those with painful DPN. Pain and dysesthesia were common in DPN and both significantly interfered with daily life. Therefore, considering dysesthesia is important in the diagnosis and treatment of neuropathy.

PLOS ONE (2022)

Article Medical Informatics

Classification of painful or painless diabetic peripheral neuropathy and identification of the most powerful predictors using machine learning models in large cross-sectional cohorts

Georgios Baskozos, Andreas C. Themistocleous, Harry L. Hebert, Mathilde M. Pascal, Jishi John, Brian C. Callaghan, Helen Laycock, Yelena Granovsky, Geert Crombez, David Yarnitsky, Andrew S. C. Rice, Blair H. Smith, David L. H. Bennett

Summary: This study used machine learning models to classify painful and painless Diabetic Peripheral Neuropathy (DPN) and identified important predictors such as quality of life, personality traits, and clinical variables. The models showed good performance in accurately classifying DPN and have potential clinical applications for improving diagnosis and outcomes.

BMC MEDICAL INFORMATICS AND DECISION MAKING (2022)

Article Clinical Neurology

Neuropathy and pain after breast cancer treatment: a prospective observational study

Kristine Bennedsgaard, Kasper Grosen, Nadine Attal, Didier Bouhassira, Geert Crombez, Troels S. Jensen, David L. Bennett, Lise Ventzel, Inge S. Andersen, Nanna B. Finnerup

Summary: This study investigated the symptoms, intensity, and interference of chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors. It found that although less common, foot pain in patients who received chemotherapy was more intense and had a higher interference with daily life compared to pain in the surgical area.

SCANDINAVIAN JOURNAL OF PAIN (2023)

Review Clinical Neurology

Acute small fiber neuropathy after Oxford-AstraZeneca ChAdOx1-S vaccination: A report of three cases and review of the literature

Molly G. Abbott, Zahra Allawi, Monika Hofer, Olaf Ansorge, Stefen Brady, Ricardo Fadic, Gustavo Torres, Ravi Knight, Margarita Calvo, David L. H. Bennett, Andreas C. Themistocleous

Summary: This article describes three cases of acute small fiber neuropathy following Oxford-AstraZeneca ChAdOx1-S vaccination. The patients presented with neuropathic pain symptoms accompanied by clinical findings, but laboratory tests and imaging studies showed no significant abnormalities. The symptoms persisted for several months in two cases.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2022)

Article Clinical Neurology

Electroencephalography functional connectivity-A biomarker for painful polyneuropathy

Leah Shafran Topaz, Alex Frid, Yelena Granovsky, Rabab Zubidat, Shoshana Crystal, Chen Buxbaum, Noam Bosak, Rafi Hadad, Erel Domany, Tayir Alon, Lian Meir Yalon, Merav Shor, Mogher Khamaisi, Irit Hochberg, Nataliya Yarovinsky, Zeev Volkovich, David L. Bennett, David Yarnitsky

Summary: This study successfully differentiated painful from non-painful diabetic polyneuropathy patients using resting state EEG data analysis. The functional connectivity derived from EEG can serve as a biomarker for the presence or absence of pain in these patients.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study

Harry L. Hebert, Abirami Veluchamy, Georgios Baskozos, Francesca Fardo, Dimitri Van Ryckeghem, Ewan R. Pearson, Lesley A. Colvin, Geert Crombez, David L. H. Bennett, Weihua Meng, Colin N. A. Palmer, Blair H. Smith

Summary: This study aimed to develop and externally validate two clinical risk models for predicting onset and resolution of chronic neuropathic pain. The models included psychosocial and lifestyle factors, and showed adequate discrimination but miscalibration in external validation. These risk models are of significant importance for patients and clinicians, as they can guide preventive and remedial measures.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Maximizing treatment efficacy through patient stratification in neuropathic pain trials

Ralf Baron, Anthony H. Dickenson, Margarita Calvo, Sulayman D. Dib-Hajj, David L. Bennett

Summary: Despite research advances, treatment of neuropathic pain is still inadequate. Rational stratification of patients and development of outcome measures could improve treatment outcomes, but further research is needed for their application in clinical practice and trials.

NATURE REVIEWS NEUROLOGY (2023)

Article Clinical Neurology

Joint European Academy of Neurology-European Pain Federation-Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment

Andrea Truini, Katina Aleksovska, Cristopher C. Anderson, Nadine Attal, Ralf Baron, David L. Bennett, Didier Bouhassira, Giorgio Cruccu, Elon Eisenberg, Elena Enax-Krumova, Karen Deborah Davis, Giulia Di Stefano, Nanna B. Finnerup, Luis Garcia-Larrea, Ibrahem Hanafi, Simon Haroutounian, Pall Karlsson, Martin Rakusa, Andrew S. C. Rice, Juliane Sachau, Blair H. Smith, Claudia Sommer, Thomas Toelle, Josep Valls-Sole, Abirami Veluchamy

Summary: This article aims to develop evidence-based recommendations for the use of screening questionnaires and diagnostic tests in patients with neuropathic pain. Researchers systematically reviewed studies to assess the sensitivity and specificity of various screening questionnaires and diagnostic tests, and provided corresponding recommendations. However, further large-scale, well-designed, multicenter studies are needed to evaluate the accuracy of these diagnostic tests.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Review Neurosciences

New perspectives in diabetic neuropathy

Stephanie A. Eid, Amy E. Rumora, Bogdan Beirowski, David L. Bennett, Junguk Hur, Masha G. Savelieff, Eva L. Feldman

Summary: The prevalence of diabetes is increasing due to the aging population, with type 2 diabetes being the most common type. Diabetic peripheral neuropathy is a complication that damages peripheral nerves and is influenced by metabolic and bioenergetic dysfunction. Recent evidence suggests that obesity and dyslipidemia also contribute to this condition.

NEURON (2023)

暂无数据